Researchers have long dreamed of developing simple blood tests to monitor and diagnose solid tumors, but the scarcity of circulating cancer biomarkers has held the field back. Highly sensitive assays and innovative strategies are finally changing that, and bringing a new era of liquid biopsies closer than ever.